ORMP ORAMED PHARMACEUTICALS INC.

$3.88 +2.37%

Healthcare · Pharmaceutical Preparations

ORAMED PHARMACEUTICALS INC. (ORMP) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $159 million. Shares last traded at $3.88, 21.8% below their 52-week high. Over the past year the stock is up 83.3%. ORMP trades at a price-to-earnings ratio of 2.48, below the Pharmaceutical Preparations median of 16.82. Net profit margin is 3202.5%, above the peer median of -0.1%. Revenue grew 49.3% year over year.

Market Cap

$159M

Shares Out

40.9M

EPS (TTM)

$2.11

P/E Ratio

1.84

P/S Ratio

79.50

P/B Ratio

0.67

Dividend / Share

—

Dividend Yield

—

52-Week High

$4.97

52-Week Low

$2.06

Volume

6,898

Avg Vol (3m)

10,574.857

Performance

+2.24%

-10.48%

+7.32%

+25.32%

YTD

+33.28%

+83.25%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

50.01

SMA (50)

$3.96

SMA (200)

$3.18

Price vs SMA50

-1.93%

Price vs SMA200

+22.36%

ATR (14)

$0.18

Financials

Revenue

$2M

Net Income

$64M

Gross Margin

0.7%

Operating Margin

-754.4%

Net Margin

3202.5%

Return on Equity

26.9%

Return on Assets

23.8%

Current Ratio

6.45

Debt / Equity

0.31

Revenue Growth (YoY)

+49.3%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.91	2026-05-19
FY 2025	$1.50	2026-03-26
Q3 2025	$1.26	2025-11-13
Q2 2025	$0.13	2025-08-14
Q1 2026	$-0.19	2026-05-19
FY 2025	$-0.48	2026-03-26

Full earnings history →

Pharmaceutical Preparations peers

ORMP vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

2.48 / 16.82 med

-85% discount

P/S vs peers

79.50 / 3.54 med

+2147% premium

Net margin vs peers

3202.5% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.